Table 1.
51 Reported cases of MAHA associated with breast cancer
| Author | Age | Bone marrow metastasis | Intervention | Prognosis (survival time) | Notes |
|---|---|---|---|---|---|
| Pendse et al. (2014) | 69 | + | None | Soon death | |
| Kok et al. (2014) | 43 | Bone meta only | Discontinuation of GEM | Recovery | s/o GEM induced MAHA |
| Lechner and Obermeier (2012) (case reports review included 36 breast cancer cases) | Average 54 (19–82) | 24/36 | Each cases | 4 months (chemotherapy) Half a month (no treatment) |
|
| George (2011) | 52 | + | Plasma exchange | 3 days | Death due to micro thrombi in multiple organs |
| Himmelmann and Schefer (2009) | 66 | – | None | 10 days | |
| Lockhart (2001) | Unknown (middle age) | + | Chemotherapy | Survival for more than 1 year | |
| Fontana et al. (2001) (Case A) | 69 | + | Chemotherapy | No description of death | |
| Fontana et al. (2001) (Case B) | 62 | + | None | 4 days | |
| Fontana et al. (2001) (Case C) | 60 | + | None | 1 day | Death due to pulmonary embolism |
| Ataga and Graham (1999) | 46 | + | None | 7 days | |
| Narita et al. (1997) | 45 | + | Chemoendcrinetherapy | No description of death | |
| Nordstrom and Strang (1993) | 58 | + | Chemotherapy | 12 months | |
| Bastecky et al. (1992) | 28 | + | None | 10 days | Death due to pulmonary embolism |
| Collins et al. (1991) | 54 | + | Chemotherapy and plasma exchange | No description of death | |
| N Engl J Med Case Record. (1984) | 53 | Unknown | Plasma exchange | 4 days | Death due to tumor embolism in liver |
| Own case 2015 | 54 | − | Chemotherapy | 13 months |
The literature was extracted from 1984 to 2015
GEM gemcitabine